The Journal of the American Medical Association (JAMA) recently published Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. This study compared the effectiveness of six different treatment pathways across...
...recall included several compounded opioid products, including various lots of fentanyl, morphine, and hydromorphone compounds, along with certain lots of benzodiazepine compounds that included midazolam. The expanded recall now includes...
...and opioid overdose. The study involved a population-based, county-level analysis that compared three sets of data. The first data set was industry marketing information pulled from the Centers for Medicare...
...impacts healthcare professionals across the board, including those in the workers’ compensation industry. Earlier in March, the United States Senate Special Committee on Aging held a hearing on the complex web...
...to figure out in the coming months and years, there is now a stronger likelihood that marijuana will make its way more into workers’ comp on some level or another....
...of an evidence-based drug formulary for workers’ compensation claims. The bill prohibits workers’ compensation and occupational disease compensation reimbursements for drugs specified as “not recommended” in the Official Disability Guidelines...
On June 24th, Healthesystems attended the Washington’s Workers' Compensation Advisory Committee’s (WCAC) quarterly meeting, which focused on the rise in long-term disability claims. Factors contributing to long-term disability claims include...
Illinois House Bill 1256 was introduced, written to restrict reimbursement for custom compound medications to a one-time, seven-day supply, payable only if no commercial equivalent exists and all active ingredients...
...is that the company would cease to operate in its current form and would instead emerge from bankruptcy as a public benefit company (PBC) owned by a trust or similar...
...in per-fill price increased 40.4% overall. While cancer is not the most common condition found in workers’ comp claims, it is prevalent enough that drug trends impacting cancer can make...
The California Pharmacy and Therapeutic (P&T) Committee will hold a hybrid meeting on April 16th at 12:30 PM PST to discuss key issues related to the workers' compensation drug formulary....
...the differences between workers’ comp and group health PBMs and the specific value that workers’ comp PBMs bring to the table. Sandy Shtab was one of three panelists, joining Sean...
The Texas Department of Insurance will host a CompCourses webinar on December 11th at 1:00 PM CST, focusing on compliance within the Texas workers' comp system. The webinar will provide...
